|
AU5398300A
|
|
Excitatory amino acid receptor modulators
|
|
ES2131463A1
|
|
Derivatives of cyclopropylglycin with pharmaceutical properties.
|
|
ES2133095A1
|
|
Alkylidenglutaminic acids with pharmaceutical properties.
|
|
ES2133072A1
|
|
Glycine derivatives n-substituted with therapeutic activity on the central nervous system.
|
|
EP0818198A1
|
|
Potentiation of drug response by increasing serotonin availability
|
|
ES2103682A1
|
|
Oral pharmaceutical composition of fluoxetine, solid and with improved organoleptic characteristics.
|
|
ES2103681A1
|
|
Preparation procedure of n-methyl-3-phenyl - (p-trifluorometilfenoxi) propylamine.
|
|
ES2103680A1
|
|
Procedure for the preparation of n-methyl-3-phenyl-3- (p-trifluoromethylphenoxy) propylamine.
|
|
ES2101655A1
|
|
N-methyl-3-phenyl-3- (p-trifluorometilfe noxi) propylamine preparation procedure.
|
|
ES2101654A1
|
|
N-methyl-3-phenyl-3- (p-trifluorometilfe noxi) propylamine preparation procedure.
|
|
CA2154413A1
|
|
Fluoxetine pharmaceutical formulations
|
|
ES2101650A1
|
|
Procedure for the preparation of n-methyl-3-phenyl-3- (p-trifluoromethylphenoxy) propylamine.
|
|
ES2079327A1
|
|
PHARMACEUTICAL FORMULATIONS OF CEFACLOR.
|
|
ES2082723A1
|
|
PHARMACEUTICAL FORMULATION OF FLUOXETINE IN A DISPERSIBLE FORM.
|
|
ES2067388A1
|
|
Procedure for the production of configuration pyroglutamate derivatives 2,4-cis
|
|
ES2008635A6
|
|
Thiophene carboxamide deriv. prepn.
|
|
ES2008633A6
|
|
Amino-thiophene deriv prepn.
|
|
ES2008636A6
|
|
Thiophene carboxamide deriv. prepn.
|
|
ES2008634A6
|
|
Amino-thiophene deriv. prepn.
|
|
ES2008631A6
|
|
Thiophene carboxamide
|
